跳至主要内容
临床试验/ACTRN12612000011886
ACTRN12612000011886已完成4 期

A randomised, double blind, placebo controlled trial of Azithromycin versus Amoxycillin-Clavulanic Acid to treat mild to moderate respiratory exacerbations in children with non-Cystic Fibrosis bronchiectasis, Study One.

Qld Children's Medical Research Institute0 个研究点目标入组 189 人开始时间: 2012年1月4日最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
189

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
o limit 至 19 Years(—)
性别
All

入选标准

  • Aged less than 18 years.
  • Bronchiectasis, as defined by HRCT scan within the last 5-years OR followed by a respiratory physician for treatment of bronchiectasis if diagnosed earlier.
  • 2 or more respiratory exacerbations of bronchiectasis symptoms in the 18 months prior to study enrolment.

排除标准

  • Cystic Fibrosis (defined as measurement of sweat chloride >35mmol/L or by gene mutation). Liver dysfunction. Severe (hypoxic, dyspnoea or hospitalisation required) or recent exacerbation (in the 4 weeks prior to study enrolment). Known hypersensitivity to penicillins or macrolides. Taking regular maintenance antibiotics of the same class as the investigational antibiotics (macrolides and penicillins), or has taken macrolides or penicillins in the 3 weeks prior to study enrolment. Current or recent (within 4 months prior to study enrolment) identification of pseudomonas organism in the airways.

研究者

发起方
Qld Children's Medical Research Institute

相似试验

进行中(未招募)
1 期
A randomised, double blind, placebo controlled trial to evaluate the safety, efficacy and pharmakokinetics of Pleconaril as an add on to AchEI/memantine for treatment of patients with Alzheimer’s diseaseAlzheimer's disease
EUCTR2017-004125-32-CZApodemus Aktiebolag120
进行中(未招募)
1 期
A randomised, double blind, placebo controlled trial to evaluate the safety, efficacy and pharmakokinetics of Pleconaril as an add on to AchEI/memantine for treatment of patients with Alzheimer’s diseaseMedDRA version: 20.0Level: LLTClassification code 10001896Term: Alzheimer's diseaseSystem Organ Class: 100000004852Alzheimer's disease
EUCTR2017-004125-32-PLApodemus Aktiebolag120
已完成
3 期
Investigating the feasibility and acceptability of synbiotic supplementation in patients with chronic kidney disease (pre-dialysis)Renal and Urogenital - Kidney diseaseDiet and Nutrition - Other diet and nutrition disordersChronic Kidney Disease
ACTRN12617000324314A/Prof Katrina Campbell68
已完成
3 期
A topical cold sore treatment containing St John's Wort, Calendula and CopperHerpes Simplex LabialisSkin - Dermatological conditionsAlternative and Complementary Medicine - Herbal remediesInfection - Other infectious diseases
ACTRN12618000890235Western Sydney University272
进行中(未招募)
不适用
A randomised, double blind, placebo controlled trial of doxycycline in lymphangioleiomyomatosis. - Doxycycline in LAMymphangioleiomyomatosisMedDRA version: 9.1Level: LLTClassification code 10049459Term: LymphangioleiomyomatosisMedDRA version: 9.1Level: PTClassification code 10049459Term: Lymphangioleiomyomatosis
EUCTR2007-003745-32-GBniversity of Nottingham